We describe a 49-year-old woman who presented with continuous bilateral lumbago. As the patient's ultrasonography manifestations were very similar to those of bilateral hydronephrosis, we performed retrograde pyelography and ureteroscopy. However, apart from slight left ureteropelvic junction obstruction, there was no hydronephrosis. Since malignant disease could not be completely denied, computed tomography-guided biopsy was performed. However, the tissue did not show evidence of malignancy. As the patient continued to have lumbago, we measured serum IgG4 levels because of suspicion of retroperitoneal fibrosis secondary to IgG4-related disease, which proved to be high. Further, immunostaining of the renal pelvic biopsy samples showed IgG4-positive cells. Therefore, diagnosing IgG4-related retroperitoneal fibrosis, we administered corticosteroids. The patient responded favorably to the drug, with gradual regression of the lesion.

Keywords:
IgG4-related disease, Retroperitoneal fibrosis, Hydronephrosis
1.
Uehara T, Hamano H, Kawakami M, Koyama M, Kawa S, Sano K, Honda T, Oki K, Ota H: Autoimmune pancreatitis-associated prostatitis: distinct clinicopathological entity. Pathol Int 2008;58:118-125.
2.
Nishimori I, Kohsaki T, Onishi S, Shuin T, Kohsaki S, Ogawa Y, Matsumoto M, Hiroi M, Hamano H, Kawa S: IgG4-related autoimmune prostatitis: two cases with or without autoimmune pancreatitis. Intern Med 2007;46:1983-1989.
3.
Kamisawa T, Okamoto A: IgG4-related sclerosing disease. World J Gastroenterol 2008;14:3948-3955.
4.
Stone JH, Zen Y, Deshpande V: IgG4-related disease. New Engl J Med 2012;366:539-551.
5.
Guma M, Firestein GS: IgG4-related diseases. Best Pract Res Clin Rheumatol 2012;26:425-438.
6.
Yoshino T, Moriyama H, Fukushima M, Sanda N: A case of IgG4-related retroperitoneal fibrosis mimicking renal pelvic cancer. Urol Int 2013;90:365-368.
7.
Kuroda N, Nakamura S, Miyazaki K, Inoue K, Ohara M, Mizuno K, Sato Y, Yoshino T: Chronic sclerosing pyelitis with an increased number of IgG4-positive plasma cells. Med Mol Morphol 2009;42:236-238.
8.
Umehara H, Okazaki K, Masaki Y, Kawano M, Yamamoto M, Saeki T, Matsui S, Yoshino T, Nakamura S, Kawa S, Hamano H, Kamisawa T, Shimosegawa T, Shimatsu A, Nakamura S, Ito T, Notohara K, Sumida T, Tanaka Y, Mimori T, Chiba T, Mishima M, Hibi T, Tsubouchi H, Inui K, Ohara H: Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD). Mod Rheumatol 2012;22:21-30.
9.
Ryu JH, Sekiguchi H, Yi ES: Pulmonary manifestations of immunoglobulin G4-related sclerosing disease. Eur Respir J 2012;39:180-186.
10.
Zen Y, Onodera M, Inoue D, Kitao A, Matsui O, Nohara T, Namiki M, Kasashima S, Kawashima A, Matsumoto Y, Katayanagi K, Murata T, Ishizawa S, Hosaka N, Kuriki K, Nakanuma Y: Retroperitoneal fibrosis: a clinicopathologic study with respect to immunoglobulin G4. Am J Surg Pathol 2009;33:1833-1839.
© 2014 S. Karger AG, Basel
2014
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.